Patent Assignment
Reel/Frame 068284/0511
Assignment of Assignor's Interest
Recorded: 2024-08-14
Pages: 11
Assignor
EIGER BIOPHARMACEUTICALS, INC.
Executed: 2024-07-09
Assignee
AMYLYX PHARMACEUTICALS, INC.
43 THORNDIKE STREET, CAMBRIDGE, MASSACHUSETTS, 02141
Covered Properties
(2)
Treatment of Congenital Hyperinsulinism with Avexitide
Treatment of Congenital Hyperinsulinism with Avexitide
Application:
63/213,051 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 24, 2021
From: CRAIG, COLLEEN M
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 056646/0857 →
Security Interest
Jun 10, 2022
From: EIGER BIOPHARMACEUTICALS, INC.; EB PHARMA, LLC; EBPI MERGER, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
Reel/Frame 060156/0901 →
Assignment of Assignor's Interest
Jun 27, 2022
From: CRAIG, COLLEEN M.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 060317/0355 →
Assignment of Assignor's Interest
Dec 19, 2023
From: CRAIG, COLLEEN M.
To: EIGER BIOPHARMACEUTICALS, INC.
Reel/Frame 065914/0578 →
Assignment of Assignor's Interest
Sep 24, 2024
From: EIGER BIOPHARMACEUTICALS, INC.
To: AMYLYX PHARMACEUTICALS, INC.
Reel/Frame 068683/0015 →